Critical trials of morantel tartrate in equine strongylosis.
D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D006736:Horses; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy / Q000662:veterinary; D008297:Male; D009198:Myiasis / Q000188:drug therapy / Q000662:veterinary; D010270:Parasite Egg Count; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D013217:Starvation; D013319:Strongyle Infections, Equine / Q000188:drug therapy*; D013644:Tartrates / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D014236:Trichlorfon / Q000627:therapeutic use
D000871:Anthelmintics; D011743:Pyrimidines; D013644:Tartrates; D013876:Thiophenes; D014236:Trichlorfon